Bio-Rad Labs (BIO) Q4 Revs Beat Views
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $297.09 --0%
Revenue Growth %: -4.3%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
PKE, LNN, More
Revenue Growth %: -4.3%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $2.32, which includes tax gains and does not compare to the analyst estimate of $1.26. Revenue for the quarter came in at $620.4 million versus the consensus estimate of $619.15 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lindsay (LNN) Tops Q3 EPS by 18c, Misses on Revenue
- Tesla Q2 deliveries reach 480,126, topping estimates of 406,024
- FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
